# TITRATE (inducTIon for acuTe ulceRATivE Colitis)

> **NCT03937609** · PHASE4 · TERMINATED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 50 (actual)

## Conditions studied

- Colitis, Ulcerative

## Interventions

- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT03937609
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-04
- **Primary completion:** 2024-12-15
- **Final completion:** 2024-12-15
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** Slow recruitment
- **Last updated:** 2025-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03937609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03937609, "TITRATE (inducTIon for acuTe ulceRATivE Colitis)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03937609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*